Author name: Fannie Pena

Generic erectile dysfunction medications are among the most widely used and most questioned drugs in modern sexual medicine. Patients frequently ask whether the lower price comes with hidden trade-offs: Are generics really as effective? Are they safe? Do they work the same every time? These concerns are understandable, especially when treatment involves something as personal […]

Introduction Erectile dysfunction treatment is entering a period of rapid transition. For more than two decades, care has been dominated by oral phosphodiesterase type 5 inhibitors effective for many, but fundamentally symptom-oriented rather than restorative. While these medications remain a cornerstone of therapy, their limitations are increasingly apparent: variable response rates, incomplete efficacy in vascular

Introduction Choosing an erectile dysfunction medication is often portrayed as a simple decision: pick a pill, take it before sex, and expect reliable results. In reality, selecting the right therapy is a clinical risk-benefit exercise that hinges on far more than brand recognition or headline efficacy rates. Differences in speed of action, duration of effect,

TL;DR What ED may signal Why it matters What to do next Early vascular disease (endothelial dysfunction / atherosclerosis) ED often appears 2–5 years before a first major cardiovascular event Assess blood pressure, lipids, smoking, weight, activity; consider cardiovascular risk stratification Hidden metabolic disease (insulin resistance, prediabetes, type 2 diabetes) ED can be an early